CellCentric is a privately-owned business, supported by experienced international venture capital investors

Share this:

Our lead investors

CellCentric’s lead investors are Morningside Venture Investments Ltd and Providence Investment Company Ltd.

Other investors

Other funding has come from the Takeda Ventures Inc, The Rainbow Seed Fund, Avlar BioVentures, the National Endowment for Science Technology and the Arts (NESTA), and Cambridge University.